A Chinese study shows lowering blood pressure below 120 mm Hg in diabetics may reduce major heart risks.
A Chinese study, the BPROAD trial, found that lowering systolic blood pressure (BP) to below 120 mm Hg in patients with type 2 diabetes reduced the risk of major cardiovascular events by 21% compared to a standard BP target of less than 140 mm Hg. The study involved over 12,800 patients across China and suggests that intensive BP treatment could prevent strokes and heart attacks in diabetic patients. However, experts note that the results may not directly apply to patients outside of China.
November 16, 2024
6 Articles